Consistent with the aforementioned animal studies, the results revealed that, with the reduction of WT1-positive cells, nuclear METTL14 expression was significantly elevated in biopsy samples of patients with FSGS and DN in comparison to healthy controls or patients with MCD (Fig. 2A, B). The gene discussed is METTL14; the disease is focal segmental glomerulosclerosis.